라마단 금식을 하는 제2형 당뇨병 환자에서 오르포르글리프론(LY3502970)의 연구

The purpose of this study is to test the efficacy and safety of orforglipron in participants with T2D (type 2 diabetes) who participate in fasting during Ramadan. For each participant, the study will last up to 48 weeks with a minimum of 7 in clinic visits and 4 virtual visits.